About Sumitomo Pharma
Sumitomo Pharma is a company based in Chuo (Japan) founded in 1987. Sumitomo Pharma has completed 1 acquisition, including Myovant Sciences. Sumitomo Pharma offers products and services including Pharmaceutical Products and Regenerative Medicine.
- Headquarter Chuo, Japan
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website sumitomo-pharma.com
- Social LinkedIn Facebook YouTube
- Legal Name Sumitomo Pharma Co., Ltd.
- Latest Funding Round$312.19K (USD), Grant
May 2011
- Investors
- Investments & Acquisitions
Products & Services of Sumitomo Pharma
Sumitomo Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Regenerative Medicine.
Medications for psychiatry and neurology disorders
Cell therapy for disease treatment and improvement
Apps and channels of Sumitomo Pharma
its YouTube channel 住友ファーマ公式チャンネル has 20.1K subscribers and 30 videos.
Videos from Sumitomo Pharma
The most watched videos on Sumitomo Pharma's YouTube channel, 住友ファーマ公式チャンネル (20.1K subscribers). Click a video to play it here.
More on 住友ファーマ公式チャンネル.
Funding Insights of Sumitomo Pharma
- Total Rounds 3
- Last Round Grant — $312,194
- First Round $437,294
(Jul 2008)
- Investors Count 1
All 3 funding rounds of Sumitomo Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Sumitomo Pharma
Sumitomo Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Sumitomo Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sumitomo Pharma
16 people are tracked at Sumitomo Pharma (9 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Hiroshi Nomura | CEO | Leadership |
Yoshiharu Ikeda | Managing Executive Officer | Leadership |
Toru Kimura | Representative Director, President And CEO | Leadership |
Motoyuki Sakai | Representative Director, Executive Vice President | Leadership |
Atsuko Higuchi | Managing Executive Officer | Leadership |
Hideyuki Harada | Managing Executive Officer | Leadership |
Shigeyuki Nishinaka | Managing Executive Officer | Leadership |
Debra Phillips | Director, Clinical Development | Leadership |
Hiroyuki Baba | Managing Executive Officer | Leadership |
Naoki Noguchi | Executive Officer | Team |
Isao Shimizu | Executive Officer | Team |
Kenji Ueno | Executive Officer | Team |
Koichi Kozuki | Executive Officer | Team |
Yutaka Wakemi | Executive Officer | Team |
Nishinaka Shigeyuki | Senior Executive Officer | Team |
Yudai Furuta | Research Scientist | Team |
Complete people profiles for Sumitomo Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sumitomo Pharma
Sumitomo Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Myovant Sciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developing treatment of women’s health diseases and other endocrine-related disorders. | myovant.com | Bermuda | 2016 | Oct 2022 | $2.9B |
Complete acquisition details for Sumitomo Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sumitomo Pharma
4 dated milestones of Sumitomo Pharma across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Sumitomo Pharma is founded.
- Funding First funding round of $437K.
- Funding Latest funding round, Grant, of $312K.
- Acquisition Acquires Myovant Sciences.
Web traffic of Sumitomo Pharma
The website of Sumitomo Pharma (sumitomo-pharma.com) receives about 21.1K visits a month and ranks #1,635,262 among all websites worldwide, #2,201 in Biotechnology and Pharmaceuticals.
- Monthly visits21.1K
▲ 32% vs previous month
- Unique visitors7.5K
per month
- Global rank#1,635,262
among all websites
- Category rank#2,201
Health · Biotechnology and Pharmaceuticals
- Bounce rate44%
- Pages per visit1.7
- Average visit33 sec
- DevicesDesktop 51% · Mobile 49%
Websites whose visitors overlap most with Sumitomo Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| angelinipharma.com | 100% | 36.1K | #668,498 | View details | |
| gedeonrichter.com | 89% | 176.3K | #233,361 | View details | |
| acadia.com | 89% | 37.8K | #803,210 | View details | |
| pfizer.com | 89% | 1.9M | #24,984 | View details | |
| otsuka-us.com | 89% | 105.4K | #434,587 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Sumitomo Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Sumitomo Pharma
Complete news archive for Sumitomo Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sumitomo Pharma
10 companies that operate in the same segment as Sumitomo Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sumitomo Pharma
Sumitomo Pharma was founded in 1987 and raised its 1st funding round 21 years after it was founded.
Sumitomo Pharma is headquartered in Chuo, Japan. It is registered at Chuo, Yamanashi Prefecture, Japan.
Hiroshi Nomura is the current CEO of Sumitomo Pharma.
Sumitomo Pharma was established in 1987 in Chuo City, Japan, within the pharmaceutical sector. Research and development efforts are directed toward drug manufacturing across various therapeutic areas. Operations encompass production processes for medications addressing diverse health needs, with a primary geographic base in Japan. Leadership is provided by CEO Hiroshi Nomura, overseeing core activities in drug innovation and supply.
Sumitomo Pharma offers Pharmaceutical Products and Regenerative Medicine.
Sumitomo Pharma has made 1 acquisition, including Myovant Sciences.
Sumitomo Pharma has 1 investor. Key investors include HHS.
Sumitomo Pharma operates through Sumitomo Pharma Co., Ltd..